Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Cancer Tumor Profiling Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Cancer Tumor Profiling Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published: 2025-09-06

Pages: 104 Pages

Report ld: 4990777

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Cancer Tumor Profiling market size was US$ 49140 million in 2024 and is forecast to a readjusted size of US$ 97300 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.

Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.

Cancer Tumor Profiling Market Size(US$)

M= millions and B=billions

The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.

The global Cancer Tumor Profiling market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Report Metric
Details
Report Title
Global Cancer Tumor Profiling Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Forecasted Market Size in 2031
US$ 97300 million
CAGR(2025-2031)
10.4%
Market Size Available for Years
2025-2031
Global Cancer Tumor Profiling Companies Covered
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Global Cancer Tumor Profiling Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Tumor Profiling Market, Segment by Type
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Global Cancer Tumor Profiling Market, Segment by Application
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cancer Tumor Profiling market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Polymerase Chain Reaction (PCR) in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnostics in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.  
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?  
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cancer Tumor Profiling value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market by Type
        1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
        1.2.2 Next-generation Sequencing (NGS)
        1.2.3 Polymerase Chain Reaction (PCR)
        1.2.4 Immunohistochemistry (IHC)
        1.2.5 In Situ Hybridization (ISH)
        1.2.6 Microarray
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
        1.3.2 Personalized Medicine
        1.3.3 Diagnostics
        1.3.4 Biomarker Discovery
        1.3.5 Prognostics
        1.3.6 Research Applications
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Cancer Tumor Profiling Market Perspective (2020-2031)
    2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
    2.3 Global Cancer Tumor Profiling Revenue Market Share by Region (2020-2025)
    2.4 Global Cancer Tumor Profiling Revenue Forecast by Region (2026-2031)
    2.5 Major Region and Emerging Market Analysis
        2.5.1 North America Cancer Tumor Profiling Market Size and Prospective (2020-2031)
        2.5.2 Europe Cancer Tumor Profiling Market Size and Prospective (2020-2031)
        2.5.3 China Cancer Tumor Profiling Market Size and Prospective (2020-2031)
        2.5.4 Japan Cancer Tumor Profiling Market Size and Prospective (2020-2031)
        2.5.5 Southeast Asia Cancer Tumor Profiling Market Size and Prospective (2020-2031)
        2.5.6 India Cancer Tumor Profiling Market Size and Prospective (2020-2031)
        2.5.7 Central & South America Cancer Tumor Profiling Market Size and Prospective (2020-2031)

3 Breakdown Data by Type
    3.1 Global Cancer Tumor Profiling Historic Market Size by Type (2020-2025)
    3.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2026-2031)
    3.3 Different Types Cancer Tumor Profiling Representative Players

4 Breakdown Data by Application
    4.1 Global Cancer Tumor Profiling Historic Market Size by Application (2020-2025)
    4.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2026-2031)
    4.3 New Sources of Growth in Cancer Tumor Profiling Application

5 Competition Landscape by Players
    5.1 Global Top Players by Revenue
        5.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2020-2025)
        5.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2020-2025)
    5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    5.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue
    5.4 Global Cancer Tumor Profiling Market Concentration Analysis
        5.4.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
        5.4.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2024
    5.5 Global Key Players of Cancer Tumor Profiling Head office and Area Served
    5.6 Global Key Players of Cancer Tumor Profiling, Product and Application
    5.7 Global Key Players of Cancer Tumor Profiling, Date of Enter into This Industry
    5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
    6.1 North America Market: Players, Segments and Downstream
        6.1.1 North America Cancer Tumor Profiling Revenue by Company (2020-2025)
        6.1.2 North America Market Size by Type
            6.1.2.1 North America Cancer Tumor Profiling Market Size by Type (2020-2025)
            6.1.2.2 North America Cancer Tumor Profiling Market Share by Type (2020-2025)
        6.1.3 North America Market Size by Application
            6.1.3.1 North America Cancer Tumor Profiling Market Size by Application (2020-2025)
            6.1.3.2 North America Cancer Tumor Profiling Market Share by Application (2020-2025)
        6.1.4 North America Market Trend and Opportunities
    6.2 Europe Market: Players, Segments and Downstream
        6.2.1 Europe Cancer Tumor Profiling Revenue by Company (2020-2025)
        6.2.2 Europe Market Size by Type
            6.2.2.1 Europe Cancer Tumor Profiling Market Size by Type (2020-2025)
            6.2.2.2 Europe Cancer Tumor Profiling Market Share by Type (2020-2025)
        6.2.3 Europe Market Size by Application
            6.2.3.1 Europe Cancer Tumor Profiling Market Size by Application (2020-2025)
            6.2.3.2 Europe Cancer Tumor Profiling Market Share by Application (2020-2025)
        6.2.4 Europe Market Trend and Opportunities
    6.3 China Market: Players, Segments and Downstream
        6.3.1 China Cancer Tumor Profiling Revenue by Company (2020-2025)
        6.3.2 China Market Size by Type
            6.3.2.1 China Cancer Tumor Profiling Market Size by Type (2020-2025)
            6.3.2.2 China Cancer Tumor Profiling Market Share by Type (2020-2025)
        6.3.3 China Market Size by Application
            6.3.3.1 China Cancer Tumor Profiling Market Size by Application (2020-2025)
            6.3.3.2 China Cancer Tumor Profiling Market Share by Application (2020-2025)
        6.3.4 China Market Trend and Opportunities
    6.4 Japan Market: Players, Segments and Downstream
        6.4.1 Japan Cancer Tumor Profiling Revenue by Company (2020-2025)
        6.4.2 Japan Market Size by Type
            6.4.2.1 Japan Cancer Tumor Profiling Market Size by Type (2020-2025)
            6.4.2.2 Japan Cancer Tumor Profiling Market Share by Type (2020-2025)
        6.4.3 Japan Market Size by Application
            6.4.3.1 Japan Cancer Tumor Profiling Market Size by Application (2020-2025)
            6.4.3.2 Japan Cancer Tumor Profiling Market Share by Application (2020-2025)
        6.4.4 Japan Market Trend and Opportunities
    6.5 Southeast Asia Market: Players, Segments and Downstream
        6.5.1 Southeast Asia Cancer Tumor Profiling Revenue by Company (2020-2025)
        6.5.2 Southeast Asia Market Size by Type
            6.5.2.1 Southeast Asia Cancer Tumor Profiling Market Size by Type (2020-2025)
            6.5.2.2 Southeast Asia Cancer Tumor Profiling Market Share by Type (2020-2025)
        6.5.3 Southeast Asia Market Size by Application
            6.5.3.1 Southeast Asia Cancer Tumor Profiling Market Size by Application (2020-2025)
            6.5.3.2 Southeast Asia Cancer Tumor Profiling Market Share by Application (2020-2025)
        6.5.4 Southeast Asia Market Trend and Opportunities
    6.6 India Market: Players, Segments and Downstream
        6.6.1 India Cancer Tumor Profiling Revenue by Company (2020-2025)
        6.6.2 India Market Size by Type
            6.6.2.1 India Cancer Tumor Profiling Market Size by Type (2020-2025)
            6.6.2.2 India Cancer Tumor Profiling Market Share by Type (2020-2025)
        6.6.3 India Market Size by Application
            6.6.3.1 India Cancer Tumor Profiling Market Size by Application (2020-2025)
            6.6.3.2 India Cancer Tumor Profiling Market Share by Application (2020-2025)
        6.6.4 India Market Trend and Opportunities

7 Key Players Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Company Details
7.1.2 Qiagen N.V. Business Overview
7.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction
7.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2020-2025)
7.1.5 Qiagen N.V. Recent Development
7.2 Roche Molecular Systems Inc.
7.2.1 Roche Molecular Systems Inc. Company Details
7.2.2 Roche Molecular Systems Inc. Business Overview
7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction
7.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2020-2025)
7.2.5 Roche Molecular Systems Inc. Recent Development
7.3 Abott Molecular
7.3.1 Abott Molecular Company Details
7.3.2 Abott Molecular Business Overview
7.3.3 Abott Molecular Cancer Tumor Profiling Introduction
7.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2020-2025)
7.3.5 Abott Molecular Recent Development
7.4 Illumina Inc.
7.4.1 Illumina Inc. Company Details
7.4.2 Illumina Inc. Business Overview
7.4.3 Illumina Inc. Cancer Tumor Profiling Introduction
7.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2020-2025)
7.4.5 Illumina Inc. Recent Development
7.5 NeoGenomics Laboratories
7.5.1 NeoGenomics Laboratories Company Details
7.5.2 NeoGenomics Laboratories Business Overview
7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction
7.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2020-2025)
7.5.5 NeoGenomics Laboratories Recent Development
7.6 HTG Molecular Diagnostic
7.6.1 HTG Molecular Diagnostic Company Details
7.6.2 HTG Molecular Diagnostic Business Overview
7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction
7.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2020-2025)
7.6.5 HTG Molecular Diagnostic Recent Development
7.7 Genomic Health Inc.
7.7.1 Genomic Health Inc. Company Details
7.7.2 Genomic Health Inc. Business Overview
7.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction
7.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2020-2025)
7.7.5 Genomic Health Inc. Recent Development
7.8 Hologic Gen-Probe
7.8.1 Hologic Gen-Probe Company Details
7.8.2 Hologic Gen-Probe Business Overview
7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction
7.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2020-2025)
7.8.5 Hologic Gen-Probe Recent Development
7.9 BD Biosciences
7.9.1 BD Biosciences Company Details
7.9.2 BD Biosciences Business Overview
7.9.3 BD Biosciences Cancer Tumor Profiling Introduction
7.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2020-2025)
7.9.5 BD Biosciences Recent Development
7.10 Siemens Healthineers
7.10.1 Siemens Healthineers Company Details
7.10.2 Siemens Healthineers Business Overview
7.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction
7.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2020-2025)
7.10.5 Siemens Healthineers Recent Development
7.11 Claris Life Sciences
7.11.1 Claris Life Sciences Company Details
7.11.2 Claris Life Sciences Business Overview
7.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction
7.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2020-2025)
7.11.5 Claris Life Sciences Recent Development
7.12 Personal Genome Diagnostics, Inc.
7.12.1 Personal Genome Diagnostics, Inc. Company Details
7.12.2 Personal Genome Diagnostics, Inc. Business Overview
7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction
7.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2020-2025)
7.12.5 Personal Genome Diagnostics, Inc. Recent Development
7.13 Perthera, Inc.
7.13.1 Perthera, Inc. Company Details
7.13.2 Perthera, Inc. Business Overview
7.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction
7.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2020-2025)
7.13.5 Perthera, Inc. Recent Development
7.14 Foundation Medicine, Inc
7.14.1 Foundation Medicine, Inc Company Details
7.14.2 Foundation Medicine, Inc Business Overview
7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction
7.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2020-2025)
7.14.5 Foundation Medicine, Inc Recent Development
7.15 V., Strand
7.15.1 V., Strand Company Details
7.15.2 V., Strand Business Overview
7.15.3 V., Strand Cancer Tumor Profiling Introduction
7.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2020-2025)
7.15.5 V., Strand Recent Development
7.16 ApoCell
7.16.1 ApoCell Company Details
7.16.2 ApoCell Business Overview
7.16.3 ApoCell Cancer Tumor Profiling Introduction
7.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2020-2025)
7.16.5 ApoCell Recent Development
7.17 Contextual Genomics
7.17.1 Contextual Genomics Company Details
7.17.2 Contextual Genomics Business Overview
7.17.3 Contextual Genomics Cancer Tumor Profiling Introduction
7.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2020-2025)
7.17.5 Contextual Genomics Recent Development
7.18 Agendia
7.18.1 Agendia Company Details
7.18.2 Agendia Business Overview
7.18.3 Agendia Cancer Tumor Profiling Introduction
7.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2020-2025)
7.18.5 Agendia Recent Development
7.19 GenScript
7.19.1 GenScript Company Details
7.19.2 GenScript Business Overview
7.19.3 GenScript Cancer Tumor Profiling Introduction
7.19.4 GenScript Revenue in Cancer Tumor Profiling Business (2020-2025)
7.19.5 GenScript Recent Development

8 Cancer Tumor Profiling Market Dynamics
    8.1 Cancer Tumor Profiling Industry Trends
    8.2 Cancer Tumor Profiling Market Drivers
    8.3 Cancer Tumor Profiling Market Challenges
    8.4 Cancer Tumor Profiling Market Restraints

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Cancer Tumor Profiling Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Cancer Tumor Profiling Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Market Cancer Tumor Profiling Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Cancer Tumor Profiling Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 5. Global Cancer Tumor Profiling Revenue Share by Region (2020-2025)
 Table 6. Global Cancer Tumor Profiling Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 7. Global Cancer Tumor Profiling Revenue Share Forecast by Region (2026-2031)
 Table 8. Global Cancer Tumor Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 9. Global Cancer Tumor Profiling Revenue Market Share by Type (2020-2025)
 Table 10. Global Cancer Tumor Profiling Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 11. Global Cancer Tumor Profiling Revenue Market Share by Type (2026-2031)
 Table 12. Representative Players of Each Type
 Table 13. Global Cancer Tumor Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 14. Global Cancer Tumor Profiling Revenue Market Share by Application (2020-2025)
 Table 15. Global Cancer Tumor Profiling Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 16. Global Cancer Tumor Profiling Revenue Market Share by Application (2026-2031)
 Table 17. New Sources of Growth in Cancer Tumor Profiling Application
 Table 18. Global Cancer Tumor Profiling Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Cancer Tumor Profiling Market Share by Players (2020-2025)
 Table 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2024)
 Table 21. Ranking of Global Top Cancer Tumor Profiling Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Cancer Tumor Profiling Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Cancer Tumor Profiling, Headquarters and Area Served
 Table 24. Global Key Players of Cancer Tumor Profiling, Product and Application
 Table 25. Global Key Players of Cancer Tumor Profiling, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America Cancer Tumor Profiling Revenue by Company (2020-2025) & (US$ Million)
 Table 28. North America Cancer Tumor Profiling Revenue Market Share by Company (2020-2025)
 Table 29. North America Cancer Tumor Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 30. North America Cancer Tumor Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Europe Cancer Tumor Profiling Revenue by Company (2020-2025) & (US$ Million)
 Table 32. Europe Cancer Tumor Profiling Revenue Market Share by Company (2020-2025)
 Table 33. Europe Cancer Tumor Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 34. Europe Cancer Tumor Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 35. China Cancer Tumor Profiling Revenue by Company (2020-2025) & (US$ Million)
 Table 36. China Cancer Tumor Profiling Revenue Market Share by Company (2020-2025)
 Table 37. China Cancer Tumor Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 38. China Cancer Tumor Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 39. Japan Cancer Tumor Profiling Revenue by Company (2020-2025) & (US$ Million)
 Table 40. Japan Cancer Tumor Profiling Revenue Market Share by Company (2020-2025)
 Table 41. Japan Cancer Tumor Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 42. Japan Cancer Tumor Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 43. Southeast Asia Cancer Tumor Profiling Revenue by Company (2020-2025) & (US$ Million)
 Table 44. Southeast Asia Cancer Tumor Profiling Revenue Market Share by Company (2020-2025)
 Table 45. Southeast Asia Cancer Tumor Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 46. Southeast Asia Cancer Tumor Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 47. India Cancer Tumor Profiling Revenue by Company (2020-2025) & (US$ Million)
 Table 48. India Cancer Tumor Profiling Revenue Market Share by Company (2020-2025)
 Table 49. India Cancer Tumor Profiling Market Size by Type (2020-2025) & (US$ Million)
 Table 50. India Cancer Tumor Profiling Market Size by Application (2020-2025) & (US$ Million)
 Table 51. Qiagen N.V. Company Details
 Table 52. Qiagen N.V. Business Overview
 Table 53. Qiagen N.V. Cancer Tumor Profiling Product
 Table 54. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 55. Qiagen N.V. Recent Development
 Table 56. Roche Molecular Systems Inc. Company Details
 Table 57. Roche Molecular Systems Inc. Business Overview
 Table 58. Roche Molecular Systems Inc. Cancer Tumor Profiling Product
 Table 59. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 60. Roche Molecular Systems Inc. Recent Development
 Table 61. Abott Molecular Company Details
 Table 62. Abott Molecular Business Overview
 Table 63. Abott Molecular Cancer Tumor Profiling Product
 Table 64. Abott Molecular Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 65. Abott Molecular Recent Development
 Table 66. Illumina Inc. Company Details
 Table 67. Illumina Inc. Business Overview
 Table 68. Illumina Inc. Cancer Tumor Profiling Product
 Table 69. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 70. Illumina Inc. Recent Development
 Table 71. NeoGenomics Laboratories Company Details
 Table 72. NeoGenomics Laboratories Business Overview
 Table 73. NeoGenomics Laboratories Cancer Tumor Profiling Product
 Table 74. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 75. NeoGenomics Laboratories Recent Development
 Table 76. HTG Molecular Diagnostic Company Details
 Table 77. HTG Molecular Diagnostic Business Overview
 Table 78. HTG Molecular Diagnostic Cancer Tumor Profiling Product
 Table 79. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 80. HTG Molecular Diagnostic Recent Development
 Table 81. Genomic Health Inc. Company Details
 Table 82. Genomic Health Inc. Business Overview
 Table 83. Genomic Health Inc. Cancer Tumor Profiling Product
 Table 84. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 85. Genomic Health Inc. Recent Development
 Table 86. Hologic Gen-Probe Company Details
 Table 87. Hologic Gen-Probe Business Overview
 Table 88. Hologic Gen-Probe Cancer Tumor Profiling Product
 Table 89. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 90. Hologic Gen-Probe Recent Development
 Table 91. BD Biosciences Company Details
 Table 92. BD Biosciences Business Overview
 Table 93. BD Biosciences Cancer Tumor Profiling Product
 Table 94. BD Biosciences Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 95. BD Biosciences Recent Development
 Table 96. Siemens Healthineers Company Details
 Table 97. Siemens Healthineers Business Overview
 Table 98. Siemens Healthineers Cancer Tumor Profiling Product
 Table 99. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 100. Siemens Healthineers Recent Development
 Table 101. Claris Life Sciences Company Details
 Table 102. Claris Life Sciences Business Overview
 Table 103. Claris Life Sciences Cancer Tumor Profiling Product
 Table 104. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 105. Claris Life Sciences Recent Development
 Table 106. Personal Genome Diagnostics, Inc. Company Details
 Table 107. Personal Genome Diagnostics, Inc. Business Overview
 Table 108. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product
 Table 109. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 110. Personal Genome Diagnostics, Inc. Recent Development
 Table 111. Perthera, Inc. Company Details
 Table 112. Perthera, Inc. Business Overview
 Table 113. Perthera, Inc. Cancer Tumor Profiling Product
 Table 114. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 115. Perthera, Inc. Recent Development
 Table 116. Foundation Medicine, Inc Company Details
 Table 117. Foundation Medicine, Inc Business Overview
 Table 118. Foundation Medicine, Inc Cancer Tumor Profiling Product
 Table 119. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 120. Foundation Medicine, Inc Recent Development
 Table 121. V., Strand Company Details
 Table 122. V., Strand Business Overview
 Table 123. V., Strand Cancer Tumor Profiling Product
 Table 124. V., Strand Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 125. V., Strand Recent Development
 Table 126. ApoCell Company Details
 Table 127. ApoCell Business Overview
 Table 128. ApoCell Cancer Tumor Profiling Product
 Table 129. ApoCell Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 130. ApoCell Recent Development
 Table 131. Contextual Genomics Company Details
 Table 132. Contextual Genomics Business Overview
 Table 133. Contextual Genomics Cancer Tumor Profiling Product
 Table 134. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 135. Contextual Genomics Recent Development
 Table 136. Agendia Company Details
 Table 137. Agendia Business Overview
 Table 138. Agendia Cancer Tumor Profiling Product
 Table 139. Agendia Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 140. Agendia Recent Development
 Table 141. GenScript Company Details
 Table 142. GenScript Business Overview
 Table 143. GenScript Cancer Tumor Profiling Product
 Table 144. GenScript Revenue in Cancer Tumor Profiling Business (2020-2025) & (US$ Million)
 Table 145. GenScript Recent Development
 Table 146. Cancer Tumor Profiling Market Trends
 Table 147. Cancer Tumor Profiling Market Drivers
 Table 148. Cancer Tumor Profiling Market Challenges
 Table 149. Cancer Tumor Profiling Market Restraints
 Table 150. Research Programs/Design for This Report
 Table 151. Key Data Information from Secondary Sources
 Table 152. Key Data Information from Primary Sources


List of Figures
 Figure 1. Cancer Tumor Profiling Product Picture
 Figure 2. Global Cancer Tumor Profiling Market Share by Type: 2024 VS 2031
 Figure 3. Next-generation Sequencing (NGS) Features
 Figure 4. Polymerase Chain Reaction (PCR) Features
 Figure 5. Immunohistochemistry (IHC) Features
 Figure 6. In Situ Hybridization (ISH) Features
 Figure 7. Microarray Features
 Figure 8. Others Features
 Figure 9. Global Cancer Tumor Profiling Market Share by Application: 2024 VS 2031
 Figure 10. Personalized Medicine
 Figure 11. Diagnostics
 Figure 12. Biomarker Discovery
 Figure 13. Prognostics
 Figure 14. Research Applications
 Figure 15. Cancer Tumor Profiling Report Years Considered
 Figure 16. Global Cancer Tumor Profiling Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Cancer Tumor Profiling Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Cancer Tumor Profiling Revenue Market Share by Region: 2020 VS 2024
 Figure 19. North America Cancer Tumor Profiling Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 20. Europe Cancer Tumor Profiling Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 21. China Cancer Tumor Profiling Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 22. Japan Cancer Tumor Profiling Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 23. Southeast Asia Cancer Tumor Profiling Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 24. India Cancer Tumor Profiling Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 25. Central & South America Cancer Tumor Profiling Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 26. Global Cancer Tumor Profiling Market Share by Players in 2024
 Figure 27. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2024)
 Figure 28. The Top 10 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2024
 Figure 29. North America Cancer Tumor Profiling Market Share by Type (2020-2025)
 Figure 30. North America Cancer Tumor Profiling Market Share by Application (2020-2025)
 Figure 31. Europe Cancer Tumor Profiling Market Share by Type (2020-2025)
 Figure 32. Europe Cancer Tumor Profiling Market Share by Application (2020-2025)
 Figure 33. China Cancer Tumor Profiling Market Share by Type (2020-2025)
 Figure 34. China Cancer Tumor Profiling Market Share by Application (2020-2025)
 Figure 35. Japan Cancer Tumor Profiling Market Share by Type (2020-2025)
 Figure 36. Japan Cancer Tumor Profiling Market Share by Application (2020-2025)
 Figure 37. Southeast Asia Cancer Tumor Profiling Market Share by Type (2020-2025)
 Figure 38. Southeast Asia Cancer Tumor Profiling Market Share by Application (2020-2025)
 Figure 39. India Cancer Tumor Profiling Market Share by Type (2020-2025)
 Figure 40. India Cancer Tumor Profiling Market Share by Application (2020-2025)
 Figure 41. Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 42. Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 43. Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 44. Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 45. NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 46. HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 47. Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 48. Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 49. BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 50. Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 51. Claris Life Sciences Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 52. Personal Genome Diagnostics, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 53. Perthera, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 54. Foundation Medicine, Inc Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 55. V., Strand Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 56. ApoCell Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 57. Contextual Genomics Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 58. Agendia Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 59. GenScript Revenue Growth Rate in Cancer Tumor Profiling Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed

Description

The global Cancer Tumor Profiling market size was US$ 49140 million in 2024 and is forecast to a readjusted size of US$ 97300 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.

Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.

The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.

The global Cancer Tumor Profiling market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cancer Tumor Profiling market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Polymerase Chain Reaction (PCR) in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnostics in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.  
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?  
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cancer Tumor Profiling value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Related Reports

Global Cancer Tumor Profiling Market Research Report 2024
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
Published: 2024-01-16
Pages: 95
USD 2900.00
(Single User License)
Cancer Tumor Profiling - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
Published: 2024-01-24
Pages: 129
USD 3950.00
(Single User License)
Global Cancer Tumor Profiling Market Insights, Forecast to 2030
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
Published: 2024-04-12
Pages: 116
USD 4900.00
(Single User License)
Global Cancer Tumor Profiling Market Research Report 2025
The global market for Cancer Tumor Profiling was valued at US$ 49140 million in the year 2024 and is projected to reach a revised size of US$ 97300 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published: 2025-02-27
Pages: 95
USD 2900.00
(Single User License)
Cancer Tumor Profiling- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cancer Tumor Profiling was estimated to be worth US$ 49140 million in 2024 and is forecast to a readjusted size of US$ 97300 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 121
USD 3950.00
(Single User License)